Live from ASH 2011: Final Results of Phase II Trial of Pegylated Liposomal Doxirubicin followed by B

mskcc has 134 videos Subscribe Here

Description: Medical oncologist David Straus discusses how sequential bexarotene does not increase response rate in patients with Kaposi's sarcoma.
Shared By : mskcc
Posted on : 01/04/12
Added : 6 years ago
Category : Soft Tissue Sarcoma

More From mskcc

Nothing found.